I took another look at this section of the 10Q about a potential second manufacturing facility in the UK and saw a word that made me read it differently.
Secondary Manufacturing in the UK. The Company continued discussions for a collaboration that could potentially lead to a second DCVax production operation in another region of the UK, using an existing established GMP facility with training of the personnel to be conducted by Advent. Since this secondary facility would not require buildout and is located in a relatively low-cost area, the Company anticipates that it could be brought online rapidly and economically. The Company is pursuing planning discussions with the party in charge of the facility.
Collaboration. So we'll be working with another entity. Maybe a company? Maybe a BP? All we know is it's some "party" that has
an existing established GMP facility
that
would not require buildout
. That sounds like a significant company. Some "party" with significant and expensive cleanrooms.
Discussions with the "party" (note the company avoids identifying what type of business/organization this is) are on-going so we don't know yet if it will materialize. When I first read this section, I concentrated on the possibility that we may be leasing or buying a second location where NWBO would handle the manufacturing. But that word - collaboration - tells me we may be working with the owners of that facility. If they come to an agreement.
Market Data 
Markets 
